Shopping Cart
Remove All
Your shopping cart is currently empty
10β,17β-dihydroxyestra-1,4-dien-3-one (DHED) is a brain-selective prodrug of 17β-estradiol, which has neuroprotective effects, improves cognitive dysfunction, and can be used to study brain damage.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $99 | - | In Stock |
| Description | 10β,17β-dihydroxyestra-1,4-dien-3-one (DHED) is a brain-selective prodrug of 17β-estradiol, which has neuroprotective effects, improves cognitive dysfunction, and can be used to study brain damage. |
| In vivo | The effect of 10β,17β-dihydroxyestra-1,4-dien-3-one (DHED) on PR expression has also been evaluated on animals. PR expression in brains taken from morphine-treated rats manifested the same response to 10β,17β-dihydroxyestra-1,4-dien-3-one or EE as in OVX rats not treated with morphine. These animals were treated with the test compounds (10β,17β-dihydroxyestra-1,4-dien-3-one 30 and 100μg/kg, EE 200μg/kg, and vehicle) via oral gavage twice per day. As indicated by optical density on film exposures, that induction of the highly estrogen-responsive gene was three fold higher in the 10β,17β-dihydroxyestra-1,4-dien-3-one - and EE-treated groups than in the vehicle-treated animals. |
| Synonyms | DHED |
| Molecular Weight | 288.38 |
| Formula | C18H24O3 |
| Cas No. | 549-02-0 |
| Smiles | O[C@@]12[C@@]3([C@]([C@]4([C@](C)(CC3)[C@@H](O)CC4)[H])(CCC1=CC(=O)C=C2)[H])[H] |
| Relative Density. | 1.24 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (277.41 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (11.44 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.